Chuck Triano | Head of Investor Relations |
Christopher Viehbacher | President and Chief Executive Officer |
Priya Singhal | Head of Development and Interim Head of Research and Global Safety and Regulatory Sciences |
Michael McDonnell | Chief Financial Officer |
Phil Nadeau | TD Cowen |
Paul Matteis | Stifel |
Geoff Meacham | Bank of America |
Salveen Richter | Goldman Sachs |
Umer Raffat | Evercore |
Alice Nettleton | Wolfe Research |
Michael Yee | Jefferies |
Robyn Karnauskas | Truist Securities |
Marc Goodman | SVB Securities |
Terence Flynn | Morgan Stanley |
Jay Olson | Oppenheimer |
Colin Bristow | UBS |
Good morning. My name is Bettina and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen First Quarter 2023 Earnings Call and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.